GlassScriptPhysician profile
Robert J Herbst
NPI 1487847331
$24,159.94
in general payments reported to CMS, 2019-2025
8 companies · $24K in 2025
The $24K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $11.92 · 2023: $15.26 · 2024: $22.95 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $24K · Food and Beverage: $73.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $23,500.00 |
| Food and Beverage | $73.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $23,531.46 | 2023-2025 | |
| Horizon Therapeutics Plc | $351.02 | 2019 | |
| Melinta Therapeutics, LLC | $176.72 | 2019 | |
| Celularity INC. | $35.00 | 2019 | |
| Paratek Pharmaceuticals, INC. | $27.53 | 2020-2024 | Nuzyra |
| Globus Medical, INC. | $18.84 | 2025 | Senza |
| Merck Sharp & Dohme LLC | $12.03 | 2019 | |
| Reprise Biomedical, INC. | $7.34 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Herbst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.